L-Carnitine (Injectable)

Dosing evidence

Dose at a Glance

Clinical / FDA-approved injectable dosing

There is not one universal clinical dose .

The FDA-approved CARNITOR injection is given intravenously.

Certain inherited metabolic disorders Dose: 50 mg/kg Route: IV F requency: Depends on the medical situation The label uses 50 mg/kg by slow IV injection or infusion.

During a serious metabolic crisis, doses may be repeated more often under medical supervision.

Hemodialysis-related deficiency Starting dose: 10–20 mg/kg dry body weight Route: IV Timing: After dialysis The dose can be adjusted based on blood carnitine levels.

Research-community dosing

Community injection protocols look very different from the FDA-approved protocol.

PeptideF ox Current PeptideFox material describes:

500 mg IM 1–3 times per week It also describes a loading approach of:

1,000 mg daily for about 14 days followed by:

500 mg 2–3 times weekly PeptideDosages PeptideDosages describes a lower-dose SC approach:

W eeks 1–2: 50 mg SC daily W eek 3 onward: 100 mg SC daily Higher community doses: up to 150–200 mg daily Duration: about 8–16 weeks Evidence level Community protocols There is no healthy-human trial proving that:

• 500 mg IM is the best dose

• 1,000 mg IM is the best loading dose

• 100 mg SC is the best daily dose

• daily SC is better than intermittent IM

• a 14-day loading phase is necessary

Frequency at a Glance

Clinical

Hemodialysis Usually given after dialysis sessions.

Some clinical studies used IV levocarnitine three times per week after dialysis.

Metabolic disorders Frequency depends on the condition.

During a serious metabolic crisis, IV doses may be given much more often.

Community

IM Commonly 1–3 times per week .

SC Commonly once daily .

Best-supported fitness frequency?

Unknown.

No controlled human study has shown that daily SC or intermittent IM is the better body-composition protocol.

Timing at a Glance

Clinical

For dialysis, the approved dose is given after the dialysis session .

Outside of specific medical instructions, there is no general FDA requirement to take injectable L-Carnitine:

• fasted

• in the morning

• before exercise

• after exercise

• with carbohydrates

Community

Two common approaches are discussed.

F asted / pre-workout Some community protocols use L-Carnitine in the morning or before exercise while fasted.

With carbohydrates Other protocols combine L-Carnitine with carbohydrates because insulin can help move carnitine into muscle.

Human research does support the basic idea that insulin can help muscle take up carnitine .

Evidence verdict Carbohydrate / insulin-assisted muscle uptake: Supported in human research Exact injectable carbohydrate protocol: Not proven F asted dosing: Makes biological sense, but better fat loss has not been proven Pre-workout timing: Has been studied experimentally, but has not been shown to be superior

Duration / Cycle at a Glance

Clinical

There is no universal cycle .

Treatment lasts as long as carnitine replacement is medically needed.

Repeated IV treatment has been studied over weeks and months.

Community

Common schedules include:

• 8–16 weeks of daily SC use

• a 14-day IM loading phase followed by maintenance

• ongoing intermittent IM use

Does it need to be cycled?

No receptor-reset cycle has been established.

L-Carnitine is not a drug that repeatedly switches a receptor on.

There is no proven reason for:

• 5 days on / 2 days off

• 8 weeks on / 4 weeks off

• a receptor reset

• a mandatory washout

Expected Results Timeline

Protocol Logic Check

Does Daily Dosing Make Sense?

Daily treatment can make sense in some medical deficiency states.

Daily SC dosing is also common in community protocols.

But no controlled healthy-person study has shown that:

daily SC L-Carnitine works better than intermittent IM L-Carnitine for fat loss or performance.

V erdict Daily dosing can make sense in some settings, but daily SC fitness use has not been proven superior.

Does 1–3 Times Weekly Make Sense?

PeptideFox uses this frequency in its IM protocol.

Three-times-weekly dosing also appears in dialysis research.

But those are not the same thing .

Dialysis studies used:

• IV administration

• weight-based dosing

• people with a medical deficiency

• dosing after dialysis

Community protocols use:

• IM injections

• fixed doses

• generally non-deficient people

• fat-loss or performance goals

V erdict The schedules may look similar, but they are not the same protocol.

Does Fasted Dosing Make Sense?

When you are fasted, the body tends to rely more heavily on fat for fuel.

That gives fasted L-Carnitine use some biological logic.

But L-Carnitine helps transport fatty acids.

It does not force stored body fat to be released.

No strong human injection study has shown that fasted IM or SC L-Carnitine produces better fat loss.

V erdict Makes sense in theory , but better fat loss has not been proven.

Does Taking It With Carbohydrates Make Sense?

There is more evidence behind this idea.

Human research shows that insulin can help skeletal muscle take up carnitine when blood carnitine is high.

A later 24-week study using L-Carnitine with carbohydrate increased muscle carnitine by about 21%.

What this supports Insulin can help muscle take up carnitine.

What it does not prove Every injection needs exactly 60–80 g of carbohydrate.

or:

Two weeks of carb-paired injections will fully load the muscle.

V erdict The basic idea is supported in humans, but the exact community injection protocol has not been proven.

Pre-Workout Timing

One human experiment used:

3 g IV L-Carnitine about 40 minutes before exercise.

So pre-exercise use has actually been studied.

But that does not prove:

• 200 mg SC pre-workout is ideal

• 500 mg IM pre-workout is ideal

• taking it before exercise produces more long-term fat loss

V erdict Pre-workout use has been studied, but it has not been shown to be the best timing.

5 Days On / 2 Days Off

L-Carnitine does not work by repeatedly stimulating a receptor.

There is no reason to assume taking weekends off “resets” how it works.

V erdict No proven reason for this schedule.

8–16 Week Cycle

Some community sources use an 8–16 week schedule.

There is no known event at week 8, 12 or 16 that suddenly makes L-Carnitine stop working or requires a break.

V erdict Community schedule, not a biological requirement.

Does It Need a Receptor Reset?

No.

L-Carnitine is not a receptor agonist.

It is part of normal metabolism and transport.

The body can control how much carnitine enters cells, but that is not the same thing as a receptor becoming desensitized .

V erdict No receptor-reset reason.

Does It Need a Washout?

There is no established:

• 2-week washout

• 4-week break

• receptor recovery period

for L-Carnitine.

V erdict No proven biological requirement.

Dose Escalation / Titration

Some community protocols use:

50 mg → 100 mg → 150 mg or similar increases.

There is no matching randomized human study proving this is the ideal way to increase L-Carnitine.

Starting lower may make sense simply to see how well someone tolerates it.

That is different from a medically proven titration schedule.

V erdict Community titration, not a study-proven schedule.

3. Community Injection Protocols

Fitness and peptide communities commonly use:

• higher-dose IM injections

• lower-dose daily SC injections

• fasted use

• pre-workout use

• carbohydrate pairing

• loading and maintenance phases

These protocols are useful to document because people actually use them.

But they should stay clearly labeled as:

Community protocols rather than:

Established clinical protocols

Common Research Dose

Approved Clinical Dosing

Certain Metabolic Disorders 50 mg/kg IV Hemodialysis 10–20 mg/kg IV after dialysis

Research Duration / Cycle Length

Clinical

No universal cycle.

Treatment depends on why the person needs carnitine.

How Often It Is Used / Frequency

Clinical

Depends on the medical condition

Dialysis

Usually after dialysis sessions.

Community Research Protocol

PeptideFox IM Protocol

Current PeptideFox material describes:

Dose: 500 mg Route: IM F requency: 1–3 times weekly It also describes a loading approach:

Loading: 1,000 mg daily for about 14 days Maintenance: 500 mg 2–3 times weekly Evidence Check IM route: Community use, not the approved route 500 mg dose: Community protocol 1–3 times weekly: Community protocol 14-day loading: Community convention Carbohydrate pairing: Basic idea has human support F ull muscle loading in about 14 days: Not proven in a matching human IM trial

PeptideDosages SC Protocol

PeptideDosages describes:

W eeks 1–2: 50 mg SC daily W eeks 3 onward: 100 mg SC daily Higher community use: up to 150–200 mg daily Duration: about 8–16 weeks Evidence Check This is a community protocol.

The exact:

• SC route

• 50 → 100 mg increase

• 8–16 week cycle

• 150–200 mg higher dose

have not been established by a matching randomized human study.

Community Protocol Comparison

Source Dose Route Frequency Duration Evidence CARNITOR metabolic disorders 50 mg/kg IV Depends on condition Clinical FDA label CARNITOR dialysis 10–20 mg/kg IV After dialysis Clinical FDA label Acute exercise study 3 g IV Single experimental dose Acute Human research PeptideF ox 500 mg IM 1– 3x/week Variable Community PeptideF ox loading 1,000 mg IM Daily ~14 days then maintenance Community PeptideDosages50–100+ mg SC Daily ~8–16 weeks Community Strongest Agreement There is no single dose that all sources agree on .

What is actually clear

• IV levocarnitine has tested clinical dosing

• IM community protocols exist

• SC community protocols exist

• these should not be blended into one “standard dose”

Expected Results Timeline, Expanded

Protocol logic check

Indication- and route-specific; no validated general fitness injection regimen.

Medical literature and study context

L-Carnitine (Injectable)

F at T ransport • Mitochondrial Energy • Carnitine Deficiency Research

At a Glance

What is L-Carnitine?

L-Carnitine is a naturally occurring compound that helps move long-chain fatty acids into mitochondria, where they can be used to make energy.

Think of it as part of the transport system that helps fat reach the part of the cell where it can be used as fuel.

Injectable pharmaceutical L-Carnitine is usually called levocarnitine.

L-Carnitine is not a peptide, hormone or stimulant .

How well studied is it?

W ell studied medically , but not for modern fitness injections L-Carnitine has been studied in humans for decades, and an FDA-approved injectable version exists.

But there is an important difference between:

medical IV levocarnitine and:

IM or SC L-Carnitine used in fitness and peptide communities for fat loss, energy or performance.

The strongest human evidence is for treating carnitine deficiency , including certain inherited metabolic disorders and deficiency in people receiving hemodialysis.

The FDA-approved injectable route is IV.

Evidence level Approved-label human evidence: Strong for carnitine deficiency Human clinical research: Extensive, but depends heavily on the condition and route F at loss / exercise research: Mixed

IM/SC fitness protocols: Limited Community protocols: Common, but not equivalent to clinical evidence

What may it help with?

Strong human evidence Carnitine deficiency Levocarnitine can replace carnitine in people whose levels are too low because of certain inherited metabolic disorders.

Dialysis-related carnitine deficiency People receiving hemodialysis can lose carnitine. Repeated IV levocarnitine reliably raises blood carnitine levels in this population.

Normal fat transport Carnitine’s role in helping long-chain fatty acids reach mitochondria is well established.

Some human evidence Increasing carnitine inside muscle Human research shows that muscle carnitine can be increased under the right conditions.

One 24-week study used oral L-carnitine L-tartrate with carbohydrate and increased muscle carnitine by about 21%.

Exercise fuel use Researchers have studied whether more carnitine changes how the body uses fat and carbohydrates during exercise.

There is some evidence that carnitine availability can affect fuel use.

That does not prove injectable L-Carnitine is a powerful performance enhancer.

Body weight and fat mass A review of randomized studies found a small average reduction in body weight, BMI and fat mass with L-Carnitine supplementation, especially in people with overweight or obesity.

Most of that research was not based on modern IM or SC injection protocols.

What has it NOT been proven to help with?

Injectable L-Carnitine has not been proven to reliably cause:

• rapid fat loss

• belly-fat targeting

• fat loss at the injection site

• large weight loss on its own

• major muscle growth

• a dramatic increase in metabolism

• guaranteed energy improvement

• reliable athletic-performance improvement

• prevention of GLP-1 fatigue

• fat loss without a calorie deficit

L-Carnitine is needed for normal fat metabolism.

That does not mean:

more L-Carnitine automatically means more fat burned.

Clinical research

Immediately after IV dosing Blood carnitine levels rise quickly after IV administration.

Within the first week In a dialysis study using 20 mg/kg after dialysis three times per week, blood carnitine levels were already substantially higher after the first week.

8–24 weeks Repeated treatment kept blood carnitine levels elevated over longer periods.

Around 24 weeks for muscle loading Getting more carnitine into muscle can take much longer than raising blood levels.

In one human study using L-Carnitine plus carbohydrate, muscle carnitine increased significantly after 24 weeks .

Clinical takeaway Blood levels can rise quickly . Muscle loading and longer-term bodycomposition changes can take much longer.

Community-Reported Timeline

Community sources report:

Within hours: the compound is available in the body 1–2 weeks: some people report changes in energy 4–8 weeks: some report body-composition changes when diet and exercise are also controlled

Important These are community reports , not averages from controlled IM or SC trials.

Navaro should call this:

Commonly reported community timeline not:

A verage time to results Claims that muscle becomes “fully loaded” after about two weeks of injections should also remain labeled as community claims.

Simple Timeline for the T op Card Clinical: blood levels rise quickly, but muscle loading and longer-term effects can take weeks to months .

Community-reported: some people report energy changes within 1–2 weeks and body-composition changes around 4–8 weeks , usually alongside diet and exercise.

Regulatory Status at a Glance

FDA approved?

Y es Prescription injectable levocarnitine is FDA approved.

FDA-approved injectable route?

IV CARNITOR injection is labeled:

F or intravenous use only .

Approved for

• carnitine deficiency caused by certain inherited metabolic disorders

• prevention and treatment of carnitine deficiency in people with end-stage

kidney disease receiving dialysis FDA approved for IM bodybuilding use?

No FDA approved for SC fat-loss use?

No FDA approved for ordinary weight loss?

No

Bottom Line

L-Carnitine itself is well studied. Modern IM and SC fitness protocols are much less studied.

The strongest clinical evidence supports:

IV levocarnitine for true carnitine deficiency .

Approved dosing includes:

50 mg/kg IV for certain metabolic disorders and:

10–20 mg/kg IV after dialysis for dialysis-related deficiency.

Community protocols are very different.

PeptideFox describes:

500 mg IM 1–3 times weekly with higher loading approaches.

PeptideDosages describes:

50–100 mg SC daily with some protocols going as high as 150–200 mg daily.

These community protocols are worth showing because people actually use them.

But they should not be presented as if they are the same as FDA-approved treatment.

Quick Logic Summary

Protocol Question Verdict Does L-Carnitine help transport fatty acids?

Y es, well established Is the FDA-approved injection IV? Y es Is 50 mg/kg IV a real clinical dose? Y es, for certain metabolic disorders Is 10–20 mg/kg after dialysis supported?

Y es Is 500 mg IM 1–3x/week proven? Community protocol Is 50–100 mg SC daily proven? Community protocol Is a 14-day loading phase necessary? Not proven Does fasted dosing make sense? Possible, but not proven better Can insulin help muscle take up carnitine?

Y es Is one exact carb-paired injection protocol proven?

No Is pre-workout timing proven better? No Does it need 5 days on / 2 off? No proven reason Does it need an 8–16 week cycle? No proven biological reason Does it need a receptor reset? No Does injecting into belly fat burn belly fat?

No evidence Can every vial use the same 2–4 week storage rule?

No Does injectable L-Carnitine make zero TMAO?

Not established

What Does L-Carnitine Actually Target?

L-Carnitine does not work by switching one receptor on.

It is part of the carnitine shuttle , which helps move long-chain fatty acids into mitochondria.

Simple version F atty acids → L-Carnitine transport system → mitochondria → energy Important parts of this system include:

• CPT-1

• carnitine-acylcarnitine translocase

• CPT-2

The body also uses transport proteins such as OCTN2 to move carnitine into cells.

V erdict W ell established

Human Half-Life

After one 20 mg/kg IV dose , the CARNITOR label reports:

Distribution half-life: about 0.6 hours T erminal half-life: about 17 hours Why this matters This does not mean:

take another dose every 17 hours.

Blood half-life does not tell us:

• how fast muscle loads with carnitine

• the best IM or SC schedule

• how quickly body composition changes

• when a maintenance injection should happen

V erdict W e know how long it stays in the blood, but that does not tell us the best fitness dosing schedule.

Blood Levels vs Muscle Levels

L-Carnitine can rise quickly in the blood after an injection.

Getting more carnitine into muscle can take much longer.

V erdict Blood levels and muscle levels are not the same thing.

Does It Build Up?

Repeated IV treatment can raise blood carnitine considerably.

But muscle does not simply absorb unlimited carnitine because the blood level is high.

Muscle uptake is controlled by the body.

V erdict Y es, blood levels can build up. Muscle uptake is much more limited and controlled.

Does the Route Match the Research?

FDA CARNITOR IV Human exercise research IV PeptideF ox community use IM PeptideDosages community use SC The approved clinical route and modern fitness routes are not the same.

V erdict IM and SC fitness protocols should not be presented as if they are the FDA-approved route.

Does Injecting Into Belly Fat Burn Belly Fat?

No evidence shows that injecting L-Carnitine into abdominal fat causes that area to lose more fat.

L-Carnitine works through normal metabolism throughout the body.

V erdict No evidence for spot fat loss.

What About TMAO?

This needs careful wording.

Oral L-Carnitine can be broken down by gut bacteria into compounds that can eventually become TMAO.

Injecting L-Carnitine avoids the first pass through the gut.

That gives injectable use a reasonable reason to produce a different TMA/TMAO pattern.

But there is not enough route-specific human evidence to promise:

Injectable L-Carnitine produces zero TMAO.

V erdict Injectable and oral L-Carnitine may differ, but “zero TMAO” is too strong a claim.

Important Research Note

Three very different types of L-Carnitine use are often mixed together online.

1. FDA-Approved IV Levocarnitine

This is a prescription medication with:

• a tested formulation

• IV administration

• weight-based clinical dosing

• human pharmacokinetic data

• specific medical uses

• product-specific handling instructions

2. Human Research

Researchers have studied L-Carnitine for:

• exercise metabolism

• muscle uptake

• insulin-assisted muscle loading

• body composition

• metabolic conditions

These studies use different forms and routes, including:

• oral

• IV

They should not automatically be used to prove an IM or SC community protocol works the same way.

Research at a Glance

Approved-Label Human Evidence

Strong There is an FDA-approved IV levocarnitine product with clear human dosing, safety and pharmacokinetic information.

Human Clinical Research

Extensive, but depends on the situation Human studies include:

• carnitine deficiency

• dialysis

• exercise

• muscle loading

• metabolism

• body composition

Observational Human Evidence

Supporting Decades of medical use provide additional safety and treatment experience.

Animal / Cell Evidence

Extensive Useful for understanding how carnitine transport and mitochondria work.

Mechanistic Evidence

Strong Carnitine’s role in transporting long-chain fatty acids into mitochondria is well established.

Community / Anecdotal Evidence

Common, but much weaker IM and SC protocols are common in fitness and peptide communities but are not validated to the same level as clinical IV levocarnitine.

Overview

L-Carnitine is a naturally occurring amino-acid derivative involved in energy metabolism.

Its best-known role is helping move long-chain fatty acids into mitochondria.

That makes L-Carnitine necessary for normal fat burning.

But:

Being necessary for fat metabolism does not mean taking more L-Carnitine automatically causes more fat loss.

For someone who is deficient, replacing carnitine can be medically important.

For a healthy person who already has enough carnitine, the benefit of injecting extra L-Carnitine is much less certain.

Evidence Strength

Overall Evidence Rating

Strong human evidence for deficiency treatment; much weaker evidence for modern IM/SC fitness use Strong evidence for

• normal fatty-acid transport

• IV levocarnitine pharmacology

• treatment of some carnitine deficiencies

• dialysis-related carnitine replacement

• increasing blood carnitine

• insulin helping muscle take up carnitine

Some human evidence for

• increasing muscle carnitine

• exercise fuel use

• modest body-weight and fat-mass changes

• some metabolic outcomes

Limited or unproven for

• high-dose IM bodybuilding protocols

• daily SC fat-loss protocols

• rapid fat loss

• belly-fat targeting

• GLP-1 fatigue treatment

• fasted superiority

• pre-workout superiority

• two-week muscle saturation

• fixed 8–16 week cycles

Category

Metabolic Support / F at T ransport / Mitochondrial Energy

Compound

L-Carnitine Pharmaceutical name:

Levocarnitine FDA-approved brand example:

CARNITOR

Compound Type

Naturally occurring amino-acid derivative L-Carnitine is not:

• a peptide

• a hormone

• a stimulant

• a GLP-1 agonist

• a growth-hormone secretagogue

Primary Research Focus

Best Established

• carnitine deficiency

• fatty-acid transport

• inherited metabolic disorders

• dialysis-related carnitine deficiency

Also Studied

• muscle carnitine uptake

• exercise fuel use

• insulin-assisted muscle loading

• body composition

• metabolic health

Not Established

• major standalone fat loss

• spot fat loss

• bodybuilding enhancement

• guaranteed energy improvement

• treatment of GLP-1 fatigue

How It Works / Transport Mechanism

L-Carnitine helps long-chain fatty acids get into mitochondria.

Simple version Think of mitochondria as the cell’s engines.

Fatty acids need help getting inside those engines.

L-Carnitine is part of that transport system.

Pathway F atty acid → L-Carnitine transport system → mitochondria → energy Important L-Carnitine helps the body use fatty acids that are already available .

It does not automatically tell fat cells to release stored body fat.

Human Exercise Research

One acute human experiment used:

3 g IV about 40 minutes before exercise This was a research experiment, not an approved fitness protocol.

Research Community

PeptideF ox 500 mg IM, 1–3 times weekly Higher loading protocols are also described.

PeptideDosages 50–100 mg SC daily with some protocols increasing toward:

150–200 mg daily

Human Muscle-Loading Research

One important muscle-loading study lasted:

24 weeks

Research Community

Common schedules include:

• 14-day loading followed by maintenance

• 8–16 weeks of daily SC use

• ongoing intermittent IM use

Evidence assessment There is no receptor-based reason L-Carnitine must be cycled.

Research Community

Commonly either:

daily SC or:

1–3 times weekly IM No good human study shows which fitness schedule is better.

Possible Benefits

Strong Human Evidence

Correcting Carnitine Deficiency Levocarnitine can replace carnitine that is abnormally low because of certain metabolic disorders or dialysis.

Supporting Normal F at T ransport Carnitine is part of the body’s normal system for moving fatty acids into mitochondria.

Some Human Evidence

Increasing Muscle Carnitine Long-term supplementation with insulin/carbohydrate support can increase muscle carnitine.

One 24-week study found about a:

21% increase in muscle carnitine.

Body W eight / F at Mass A review of human studies found small average reductions in:

• body weight

• BMI

• fat mass

Exercise Metabolism Human experiments show that carnitine can change fuel use under some conditions.

That does not prove injectable L-Carnitine is a major performance enhancer.

What It Does Not Help With, Based on Current

Evidence

Do not present L-Carnitine injections as proven to:

• cause rapid weight loss

• burn fat without a calorie deficit

• target belly fat

• burn fat where it is injected

• build significant muscle on their own

• reliably improve athletic performance

• prevent GLP-1 fatigue

• dramatically raise resting metabolism

• replace diet or exercise

Commonly Paired With

Carbohydrates / Insulin

Human research supports insulin helping muscle take up carnitine.

Classification: The basic idea is supported, but there is no proven exact injection protocol.

GLP-1 Agonists

They work through different pathways.

Classification: Not redundant, but there is no established evidence that L- Carnitine prevents GLP-1 fatigue or improves GLP-1 weight loss.

MOTS-c

Different metabolic pathways.

Classification: Makes sense in theory, but the combination has not been properly tested.

NAD+

Different role in energy metabolism.

Classification: Could be complementary, but no validated combination protocol exists.

SS-31

Different mitochondrial pathway.

Classification: Could be complementary, but the combination is unproven.

Dosage Information

CARNITOR Injection

Product: CARNITOR Compound: Levocarnitine Strength: 1 g per 5 mL Concentration: 200 mg/mL F orm: Sterile liquid solution Route: IV only Vial: Single dose Preservative: None

Metabolic Disorders

Recommended dose:

50 mg/kg IV given as a slow 2–3 minute injection or infusion .

During a severe metabolic crisis, the label allows more frequent dosing under medical supervision.

Clinical monitoring can include:

• blood carnitine

• blood chemistry

• vital signs

• overall clinical response

Hemodialysis

Recommended starting dose:

10–20 mg/kg dry body weight IV given:

after dialysis The dose can be adjusted using blood carnitine levels.

Human Clinical Research

Immediately IV L-Carnitine quickly raises blood carnitine.

Around 1 W eek Repeated dialysis dosing can substantially raise blood levels within the first week.

8–24 W eeks Repeated treatment can keep blood levels elevated over time.

Around 24 W eeks A human muscle-loading study showed a meaningful rise in muscle carnitine after 24 weeks .

Community-Reported

Community sources report:

1–2 weeks: some people notice changes in energy 4–8 weeks: some report body-composition changes when diet and exercise are also controlled Evidence W arning These are community reports , not controlled IM or SC trial averages.

Claims that muscle becomes fully loaded in about two weeks should remain labeled as community claims.

Regulatory Status

United States

FDA-approved injectable levocarnitine exists.

Approved Route IV only for CARNITOR injection.

Approved Uses

• certain inherited causes of carnitine deficiency

• prevention and treatment of carnitine deficiency in people with end-stage

kidney disease receiving dialysis Not FDA Approved F or

• IM bodybuilding protocols

• SC fat-loss protocols

• ordinary weight loss

• body recomposition

• sports performance

• GLP-1 fatigue

What Studies Have Found

Clinical IV / Dialysis Research

In one nine-week study, people receiving hemodialysis were given:

20 mg/kg IV three times per week after dialysis Blood carnitine levels rose substantially.

What This Supports

• IV use

• repeated post-dialysis dosing

• correction of low blood carnitine

• three-times-weekly treatment in this specific medical setting

What It Does Not Support

• 500 mg IM for fat loss

• 100 mg SC every day

• pre-workout SC protocols

• bodybuilding protocols

Acute Exercise Research

One healthy-human experiment used:

3 g IV L-Carnitine about:

40 minutes before exercise What This Supports

• IV L-Carnitine has been studied before exercise

• researchers have looked at its effects on exercise metabolism

What It Does Not Support

• 200 mg SC as an equivalent protocol

• 500 mg IM as an equivalent protocol

• guaranteed extra fat burning

• a standard pre-workout recommendation

Muscle Carnitine Loading Research

A 24-week human study used L-Carnitine with carbohydrate and found about a:

21% increase in muscle carnitine What This Supports

• muscle carnitine can be increased

• insulin/carbohydrate availability can help

• muscle loading can take months

What It Does Not Support

• a 14-day IM loading protocol

• guaranteed full muscle saturation in two weeks

• one exact carbohydrate dose for injections

Body Weight / Fat-Mass Research

A review of human studies found a modest average effect on:

• body weight

• BMI

• fat mass

especially in people with overweight or obesity.

What This Supports L-Carnitine may have a small body-composition effect in some people.

What It Does Not Support

• dramatic fat loss

• rapid injection-based fat loss

• spot reduction

• large results without diet or activity changes

Independent evidence

Strong for deficiency; limited for fitness injections

Evidence for medical IV treatment does not validate IM/SC fat-loss or performance protocols.

Storage

Formulation / Stability / Sterility Logic

The FDA-approved CARNITOR injection is already a sterile liquid .

It contains:

1 g in 5 mL which equals:

200 mg/mL It is supplied as a:

single-dose, preservative-free vial.

Unused solution should be discarded after opening.

Why this matters Not every product sold as injectable L-Carnitine is the same.

A compounded IM vial, SC vial or lyophilized research product may have completely different:

• concentration

• ingredients

• preservative

• storage

• expiration after opening

V erdict Use the instructions for the exact product. Do not apply one storage rule to every L-Carnitine vial.

Formulation / Stability / Sterility

CARNITOR Injection

1 g per 5 mL 200 mg/mL Sterile liquid solution Single-dose vial No preservative IV only Storage Store unopened vials at controlled room temperature.

A void excessive heat.

Do not freeze.

Once opened:

Discard any unused portion because the vial contains no preservative.

Contraindications & cautions

Safety at a Glance

Common or important effects

Reported effects include:

• nausea

• vomiting

• body odor

• stomach irritation

• diarrhea

• headache

• dizziness

• injection-site reactions

• pain

Important safety concerns Seizures Seizures have been reported in people both with and without a previous seizure history.

People who already have seizures have also reported an increase in seizure frequency or severity.

Serious allergic reactions Reported reactions include:

• anaphylaxis

• swelling of the throat

• bronchospasm

W arfarin interaction Levocarnitine may increase INR in people taking warfarin.

INR may need closer monitoring after starting L-Carnitine or changing the dose.

Major contraindications

F ormal FDA contraindications None known.

That does not mean there are no risks.

Important cautions include:

• seizure history

• warfarin use

• previous serious allergic reaction

• pregnancy

• breastfeeding

• severe kidney disease depending on the route and situation

Contraindications & Cautions

Formal Contraindications

None known That is the FDA-label wording.

This does not mean there are no important cautions.

Important Cautions

Seizure History Use caution because new or worsening seizures have been reported.

W arfarin INR may increase.

Previous Serious Allergic Reaction Serious allergic reactions have occurred.

Pregnancy Good controlled pregnancy studies are limited.

Breastfeeding The risks and benefits should be considered carefully.

Severe Kidney Disease This needs context.

The label warns about buildup of TMA/TMAO from long-term high-dose oral L-Carnitine in severe kidney dysfunction.

That does not mean kidney disease is a blanket contraindication to injectable L-Carnitine.

IV levocarnitine is actually used medically in dialysis patients.

Possible side effects

Reported Side Effects

Label-Supported Effects

Reported effects include:

• nausea

• vomiting

• body odor

• stomach irritation

• diarrhea

• headache

• dizziness

• injection-site reactions

• pain

Seizures

Seizures have been reported in people with and without a previous seizure history.

People with seizure disorders have also reported more frequent or more severe

seizures.

Serious Allergic Reactions

Reported reactions include:

• anaphylaxis

• throat swelling

• bronchospasm

Warfarin Interaction

Levocarnitine may increase INR in people taking warfarin.

Closer monitoring may be needed after starting it or changing the dose.

Compatibility

Stack / Pairing Logic

L-Carnitine + Carbohydrates / Insulin Human research supports insulin helping muscle take up carnitine.

V erdict: The basic idea is supported, but there is no proven exact injectionand-carb protocol.

L-Carnitine + GLP-1 Agonists They work differently.

V erdict: They are not redundant, but there is no good evidence that L- Carnitine prevents GLP-1 fatigue or makes GLP-1 weight loss better.

L-Carnitine + MOTS-c Different metabolic pathways.

V erdict: The combination makes sense on paper, but has not been properly tested in humans.

L-Carnitine + NAD+ Different roles in energy metabolism.

V erdict: Possible complementary effects, but no validated combination protocol.

L-Carnitine + SS-31 Different mitochondrial mechanisms.

V erdict: Possible complementary effects, but the combination has not been proven.

IV Compatibility

Under the labeled conditions, CARNITOR can be mixed with:

• 0.9% sodium chloride

• Lactated Ringer’s

for IV use under the product’s specified conditions.

Compounded / Community Injectable L-Carnitine

Do not assume CARNITOR storage rules apply to:

• compounded IM products

• SC multidose vials

• lyophilized research products

• vials mixed with bacteriostatic water

A rule such as:

“Injectable L-Carnitine lasts 2–4 weeks after mixing” cannot be applied to every product.

Simple rule Use storage instructions for the exact product and formulation.

Sources

Research Sources

1. DailyMed: CARNITOR Levocarnitine Injection Evidence type: FDA-approved prescription-drug labeling Supports:

• FDA-approved IV route

• clinical dosing for metabolic disorders

• clinical dosing for dialysis-associated carnitine deficiency

• human pharmacokinetics

• seizure warning

• serious hypersensitivity reactions

• warfarin interaction

• formulation and concentration

• single-dose vial handling

• storage and IV compatibility

https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=cf801cc4-775e-433d-9d32-e5d9a98981d3 2. Natali et al.: Acute IV L-Carnitine During Exercise Evidence type: Human experimental research Supports:

• 3 g IV L-Carnitine

• administration approximately 40 minutes before exercise

• direct human research on acute pre-exercise L-Carnitine metabolism

Does not establish a standard IM or SC performance protocol.

https://pubmed.ncbi.nlm.nih.gov/8492714/ 3. Stephens et al.: Insulin and Muscle L-Carnitine Uptake Evidence type: Human mechanistic research Supports:

• insulin can increase skeletal-muscle carnitine uptake when blood carnitine

is elevated

• muscle carnitine uptake is regulated rather than simply determined by

blood levels

• the basic biological reasoning behind carbohydrate/insulin-assisted carni-

tine loading Does not establish one specific carb-paired injectable protocol.

https://pubmed.ncbi.nlm.nih.gov/16368715/ 4. W all et al.: Chronic L-Carnitine + Carbohydrate Muscle Loading Evidence type: Human controlled research Supports:

• 24 weeks of L-Carnitine plus carbohydrate

• approximately 21% increase in muscle total carnitine

• the idea that meaningful muscle carnitine loading can take months

• carbohydrate/insulin availability helping support muscle carnitine uptake

Does not validate a 14-day IM loading protocol.

https://pubmed.ncbi.nlm.nih.gov/21224234/ 5. T alenezhad et al.: L-Carnitine and Body Composition Meta- Analysis Evidence type: Systematic review / meta-analysis of human studies Supports:

• modest average reductions in body weight

• modest reductions in BMI

• modest reductions in fat mass

• greater relevance in some people with overweight or obesity

Does not establish rapid or dramatic fat loss from IM or SC L-Carnitine injections.

https://pubmed.ncbi.nlm.nih.gov/32359762/ 6. PeptideF ox: Injectable L-Carnitine Evidence type: Community / practitioner protocol Useful for documenting:

• 500 mg IM community dosing

• 1–3 times weekly use

• community loading approaches

• fasted / pre-workout timing

• carbohydrate pairing

• community-reported results timeline

These are community practices and should not override FDA labeling or controlled human research.

https://peptidefox.com/content/l-carnitine 7. PeptideDosages: L-Carnitine Protocol Evidence type: Community research protocol Useful for documenting:

• 50 mg → 100 mg SC progression

• daily SC use

• higher community doses of approximately 150–200 mg

• 8–16 week community framework

• community reconstitution and storage practices

These are not matching FDA-approved or controlled human protocols.

https://peptidedosages.com/single-peptide-dosages/l-carnitine-200-mg-vial-dosage-protocol/

Final Takeaway

L-Carnitine is a well-established biological compound and a real FDAapproved medication, but the evidence becomes much weaker when moving from medical IV treatment to modern IM or SC fitness use.

The strongest clinical evidence supports:

IV levocarnitine for true carnitine deficiency .

FDA-labeled dosing includes:

50 mg/kg IV for certain inherited metabolic disorders and:

10–20 mg/kg IV after dialysis for dialysis-related deficiency.

Community protocols are very different.

PeptideFox describes:

500 mg IM 1–3 times weekly

with a short loading phase also discussed.

PeptideDosages describes:

50–100 mg SC daily with some community protocols going higher.

Those protocols are useful to show because they reflect how L-Carnitine is actually being used outside medicine.

But they should not be presented as if they are FDA-approved or clinically proven equivalents.

For timing:

Insulin helping muscle take up carnitine has real human support.

F asted and pre-workout use may make sense, but neither has been proven to be the best way to use injectable L-Carnitine.

For results:

Clinical: blood levels can rise quickly, while muscle loading and longer-term changes may take weeks to months .

Community-reported: some people report energy changes within 1–2 weeks and body-composition changes around 4–8 weeks , usually alongside diet and exercise. These are community reports, not controlled IM/SC averages.

And the most important distinction should remain highly visible:

FDA-approved injectable levocarnitine is IV. IM and SC L- Carnitine protocols are community/off-label protocols and should not be presented as if they are the approved clinical route or dose.

Navaro Compounds.pdf, pages 37–77.